ANIK logo

Anika Therapeutics, Inc. (ANIK)

Profile

Full Name

Anika Therapeutics, Inc.

Ticker

NASDAQ: ANIK

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

May 3, 1993

Indexes

Not included

Website

http://www.anika.com

Employees

288

Key Details

Price

$11.50(+1.68%)

Market cap

$164.93M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$119.91M(-0.73% YoY)

Annual EPS

-$3.83(+32.09% YoY)

PE ratio

-

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.50
    ANIK price is $11.50

    30-Day Relative Volume

    0.51
    ANIK 30-day relative volume is 0.51

    Price Performance

    Price Most recent change

    +1.68%
    ANIK price was up +1.68% on Jul 25, 2025

    Price YTD change

    -30.13%
    ANIK price is down -30.13% since January 1st

    Price 1-year change

    -59.38%
    ANIK price is down -59.38% year-on-year

    Price 3-year change

    -48.87%
    ANIK price is down -48.87% over the past 3 years

    Price Range

    Price All-time high

    $75.72
    ANIK price is currently -84.81% below its historical high of $75.72

    Price 3-year low

    $10.47
    ANIK price is currently +9.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $164.93M
    ANIK market capitalization is $164.93 million

    Market cap 3-year change

    -49.76%
    ANIK market capitalization is down -49.76% over the past 3 years

    Market cap All-time high

    $1.05B
    ANIK market capitalization is currently -84.24% below its historical high of $1.05 billion

    Market cap sector rank

    49.46%
    ANIK market capitalization is higher than 49.46% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -3.35%
    ANIK shares outstanding is down -3.35% year-on-year

    Shares Outstanding 3-Year Change

    -1.76%
    ANIK shares outstanding is down -1.76% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.93
    ANIK beta is 0.93

    200-day SMA

    $15.72
    ANIK price is currently -26.84% below its 200-day simple moving average

    50-day SMA

    $11.26
    ANIK price is currently +2.17% above its 50-day simple moving average

    RSI

    53.59
    ANIK 14-day relative strength index is 53.59

    Volume

    0.51
    ANIK 30-day relative volume is 0.51

    ATR

    $0.56
    ANIK average true range is $0.56

    10-day Historical Volatility

    55.56%
    ANIK 10-day historical volatility is 55.56%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $119.91M
    ANIK annual revenue is $119.91 million

    Revenue Analysts estimate

    $109.95M
    ANIK annual revenue is currently +9.06% higher than the consensus analysts' forecast

    Revenue 1-year change

    -0.73%
    ANIK annual revenue is down -0.73% year-on-year

    Revenue Sector rank

    57.67%
    ANIK annual revenue is higher than 57.67% of companies in Healthcare sector

    EPS

    EPS

    -$3.83
    ANIK annual earnings per share is -$3.83

    EPS Analysts estimate

    -$0.18
    ANIK annual earnings per share is currently +2027.78% higher than the consensus analysts' forecast

    EPS 1-year change

    +32.09%
    ANIK annual earnings per share is up +32.09% year-on-year

    EPS Sector rank

    24.58%
    ANIK annual earnings per share is higher than 24.58% of companies in Healthcare sector

    Profit

    Gross profit

    $76.00M
    ANIK annual gross profit is $76.00 million

    Gross margin

    63.38%
    ANIK annual gross profit margin is 63.38%

    Operating profit

    -$5.10M
    ANIK annual operating income is -$5.10 million

    Operating margin

    -4.25%
    ANIK annual operating profit margin is -4.25%

    Net income

    -$56.38M
    ANIK annual net profit is -$56.38 million

    Net margin

    -47.02%
    ANIK annual net profit margin is -47.02%

    Expenses

    Total expenses

    $125.01M
    ANIK annual total expenses is $125.01 million

    Operating expenses

    $81.10M
    ANIK annual total operating expenses is $81.10 million

    Cost of goods sold

    $43.91M
    ANIK annual cost of goods sold is $43.91 million

    Selling, general & administrative expenses

    $55.55M
    ANIK annual SGA is $55.55 million

    Depreciation and amortization

    $8.12M
    ANIK annual depreciation & amortization is $8.12 million

    Interest expense

    -
    ANIK annual interest expense value is unknown

    Income tax

    $6.06M
    ANIK annual income tax is $6.06 million

    EBIT & EBITDA

    EBIT

    -$5.10M
    ANIK annual earnings before interest & taxes is -$5.10 million

    EBITDA

    -$5.10M
    ANIK annual EBITDA is -$5.10 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $202.74M
    ANIK annual total assets is $202.74 million

    Non current assets

    $89.09M
    ANIK annual long term assets is $89.09 million

    Current assets

    $113.65M
    ANIK annual total current assets is $113.65 million

    Cash and cash equivalents

    $55.63M
    ANIK annual cash & cash equivalents is $55.63 million

    Accounts receivable

    $23.59M
    ANIK annual accounts receivable is $23.59 million

    Inventory

    $23.81M
    ANIK annual inventory is $23.81 million

    Liabilities

    Total liabilities

    $48.75M
    ANIK annual total liabilities is $48.75 million

    Long term liabilities

    $25.45M
    ANIK annual total long term liabilities is $25.45 million

    Current liabilities

    $23.31M
    ANIK annual total current liabilities is $23.31 million

    Accounts payable

    $5.62M
    ANIK annual accounts payable is $5.62 million

    Debt

    Total debt

    $25.93M
    ANIK annual total debt is $25.93 million

    Total debt 1-year change

    -6.52%
    ANIK annual total debt is down -6.52% year-on-year

    Long term debt

    $24.01M
    ANIK annual long term debt is $24.01 million

    Short term debt

    $1.92M
    ANIK annual short term debt is $1.92 million

    Equity & Capital

    Shareholders equity

    $153.99M
    ANIK annual stockholders equity is $153.99 million

    Book value

    $153.99M
    ANIK annual book value is $153.99 million

    Retained earnings

    $71.67M
    ANIK annual retained earnings is $71.67 million

    Working capital

    $90.35M
    ANIK annual working capital is $90.35 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $5.40M
    ANIK annual cash flow from operations is $5.40 million

    Cash from operations 1-year change

    +402.18%
    ANIK annual cash flow from operations is up +402.18% year-on-year

    Cash from investing

    -$8.33M
    ANIK annual cash flow from investing activities is -$8.33 million

    Cash from investing 1-year change

    -53.57%
    ANIK annual cash flow from investing activities is down -53.57% year-on-year

    Cash from financing

    -$12.73M
    ANIK annual cash flow from financing activities is -$12.73 million

    Cash from financing 1-year change

    -101.28%
    ANIK annual cash flow from financing activities is down -101.28% year-on-year

    CAPEX

    CAPEX

    $8.33M
    ANIK annual capital expenditures is $8.33 million

    CAPEX 1-year change

    +53.57%
    ANIK annual capital expenditures is up +53.57% year-on-year

    Free Cash Flow

    Free cash flow

    -$2.93M
    ANIK annual free cash flow is -$2.93 million

    Free cash flow 1-year change

    +59.38%
    ANIK annual free cash flow is up +59.38% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    63.38%
    ANIK annual gross profit margin is 63.38%

    Operating margin

    -4.25%
    ANIK annual operating profit margin is -4.25%

    Net margin

    -47.02%
    ANIK annual net profit margin is -47.02%

    ROA & ROE

    ROA

    -23.82%
    ANIK annual return on assets is -23.82%

    ROE

    -30.79%
    ANIK annual return on equity is -30.79%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ANIK price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ANIK price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.11
    ANIK price to book ratio is 1.11

    PB ratio Sector rank

    39.75%
    ANIK price to book ratio is higher than 39.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.56
    ANIK price to sales ratio is 1.56

    PS ratio Sector rank

    32.67%
    ANIK price to sales ratio is higher than 32.67% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $136.99M
    ANIK enterprise value is $136.99 million

    Enterprise value Sector rank

    48%
    ANIK enterprise value is higher than 48% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    41.16
    ANIK EV/EBITDA is 41.16

    EV/EBITDA Sector rank

    95.87%
    ANIK EV/EBITDA is higher than 95.87% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.88
    ANIK annual current ratio is 4.88

    Quick ratio

    3.85
    ANIK annual quick ratio is 3.85

    Leverage

    Debt to equity

    0.00
    ANIK annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ANIK annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    ANIK piotroski f-score is 6

    Altman Z-Score

    3.57
    ANIK altman z-score is 3.57

    Analyst ratings

    Recent major analysts updates

    May 12, 25 Barrington Research
    Outperform
    Mar 13, 25 Barrington Research
    Outperform
    Nov 1, 24 Barrington Research
    Outperform
    Oct 22, 24 Barrington Research
    Outperform
    Aug 9, 24 Barrington Research
    Outperform
    May 29, 24 Stephens & Co.
    Equal-Weight
    May 9, 24 Barrington Research
    Outperform
    Mar 14, 24 Stephens & Co.
    Equal-Weight
    Mar 14, 24 Barrington Research
    Outperform
    Jan 3, 24 Barrington Research
    Outperform

    Institutional Ownership

    Screeners with ANIK included

    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Anika Therapeutics, Inc.?
    • Does Anika Therapeutics, Inc. pay dividends?
    • What sector is Anika Therapeutics, Inc. in?
    • What industry is Anika Therapeutics, Inc. in?
    • What country is Anika Therapeutics, Inc. based in?
    • When did Anika Therapeutics, Inc. go public?
    • Is Anika Therapeutics, Inc. in the S&P 500?
    • Is Anika Therapeutics, Inc. in the NASDAQ 100?
    • Is Anika Therapeutics, Inc. in the Dow Jones?
    • When was Anika Therapeutics, Inc.'s last earnings report?
    • When does Anika Therapeutics, Inc. report earnings?

    What is the ticker symbol for Anika Therapeutics, Inc.?

    The ticker symbol for Anika Therapeutics, Inc. is NASDAQ:ANIK

    Does Anika Therapeutics, Inc. pay dividends?

    No, Anika Therapeutics, Inc. does not pay dividends

    What sector is Anika Therapeutics, Inc. in?

    Anika Therapeutics, Inc. is in the Healthcare sector

    What industry is Anika Therapeutics, Inc. in?

    Anika Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Anika Therapeutics, Inc. based in?

    Anika Therapeutics, Inc. is headquartered in United States

    When did Anika Therapeutics, Inc. go public?

    Anika Therapeutics, Inc.'s initial public offering (IPO) was on May 3, 1993

    Is Anika Therapeutics, Inc. in the S&P 500?

    No, Anika Therapeutics, Inc. is not included in the S&P 500 index

    Is Anika Therapeutics, Inc. in the NASDAQ 100?

    No, Anika Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Anika Therapeutics, Inc. in the Dow Jones?

    No, Anika Therapeutics, Inc. is not included in the Dow Jones index

    When was Anika Therapeutics, Inc.'s last earnings report?

    Anika Therapeutics, Inc.'s most recent earnings report was on May 9, 2025

    When does Anika Therapeutics, Inc. report earnings?

    The next expected earnings date for Anika Therapeutics, Inc. is July 30, 2025
    On this page